195 related articles for article (PubMed ID: 11157741)
21. Solution structure and peptide binding of the SH3 domain from human Fyn.
Morton CJ; Pugh DJ; Brown EL; Kahmann JD; Renzoni DA; Campbell ID
Structure; 1996 Jun; 4(6):705-14. PubMed ID: 8805554
[TBL] [Abstract][Full Text] [Related]
22. SH3 in muscles: solution structure of the SH3 domain from nebulin.
Politou AS; Millevoi S; Gautel M; Kolmerer B; Pastore A
J Mol Biol; 1998 Feb; 276(1):189-202. PubMed ID: 9514727
[TBL] [Abstract][Full Text] [Related]
23. Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain.
Pickford AR; Potts JR; Bright JR; Phan I; Campbell ID
Structure; 1997 Mar; 5(3):359-70. PubMed ID: 9083105
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
Wybenga-Groot LE; McGlade CJ
Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
[TBL] [Abstract][Full Text] [Related]
25. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
[TBL] [Abstract][Full Text] [Related]
26. Solution structure of the SH3 domain from Bruton's tyrosine kinase.
Hansson H; Mattsson PT; Allard P; Haapaniemi P; Vihinen M; Smith CI; Hard T
Biochemistry; 1998 Mar; 37(9):2912-24. PubMed ID: 9485443
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for SH3 domain-mediated high-affinity binding between Mona/Gads and SLP-76.
Harkiolaki M; Lewitzky M; Gilbert RJ; Jones EY; Bourette RP; Mouchiroud G; Sondermann H; Moarefi I; Feller SM
EMBO J; 2003 Jun; 22(11):2571-82. PubMed ID: 12773374
[TBL] [Abstract][Full Text] [Related]
28. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
[TBL] [Abstract][Full Text] [Related]
29. The cyanobacterial cytochrome b6f subunit PetP adopts an SH3 fold in solution.
Veit S; Nagadoi A; Rögner M; Rexroth S; Stoll R; Ikegami T
Biochim Biophys Acta; 2016 Jun; 1857(6):705-14. PubMed ID: 27033306
[TBL] [Abstract][Full Text] [Related]
30. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
31. Small Molecules Antagonise the MIA-Fibronectin Interaction in Malignant Melanoma.
Yip KT; Zhong XY; Seibel N; Pütz S; Autzen J; Gasper R; Hofmann E; Scherkenbeck J; Stoll R
Sci Rep; 2016 May; 6():25119. PubMed ID: 27151361
[TBL] [Abstract][Full Text] [Related]
32. Processing of MIA protein during melanoma cell migration.
Schmidt J; Bosserhoff AK
Int J Cancer; 2009 Oct; 125(7):1587-94. PubMed ID: 19521988
[TBL] [Abstract][Full Text] [Related]
33. Characterization and expression pattern of the novel MIA homolog TANGO.
Bosserhoff AK; Moser M; Buettner R
Gene Expr Patterns; 2004 Jul; 4(4):473-9. PubMed ID: 15183315
[TBL] [Abstract][Full Text] [Related]
34. Structure of the PI3K SH3 domain and analysis of the SH3 family.
Koyama S; Yu H; Dalgarno DC; Shin TB; Zydowsky LD; Schreiber SL
Cell; 1993 Mar; 72(6):945-52. PubMed ID: 7681364
[TBL] [Abstract][Full Text] [Related]
35. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for specific binding of the Gads SH3 domain to an RxxK motif-containing SLP-76 peptide: a novel mode of peptide recognition.
Liu Q; Berry D; Nash P; Pawson T; McGlade CJ; Li SS
Mol Cell; 2003 Feb; 11(2):471-81. PubMed ID: 12620234
[TBL] [Abstract][Full Text] [Related]
37. Solution structure and peptide binding studies of the C-terminal src homology 3-like domain of the diphtheria toxin repressor protein.
Wang G; Wylie GP; Twigg PD; Caspar DL; Murphy JR; Logan TM
Proc Natl Acad Sci U S A; 1999 May; 96(11):6119-24. PubMed ID: 10339551
[TBL] [Abstract][Full Text] [Related]
38. The crystal structure of the N-terminal SH3 domain of Grb2.
Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
[TBL] [Abstract][Full Text] [Related]
39. Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood.
de Vries TJ; Fourkour A; Punt CJ; Diepstra H; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(6):1066-70. PubMed ID: 10576666
[TBL] [Abstract][Full Text] [Related]
40. Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2.
Kohda D; Terasawa H; Ichikawa S; Ogura K; Hatanaka H; Mandiyan V; Ullrich A; Schlessinger J; Inagaki F
Structure; 1994 Nov; 2(11):1029-40. PubMed ID: 7881903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]